Biogen’s Leqembi iqlik autoinjector available in U.S. for early Alzheimer’s
Eisai and Biogen said the Leqembi iqlik (lecanemab-irmb) autoinjector is now available in the U.S. to initiate therapy for early Alzheimer’s disease.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Biogen's Leqembi Iqlik autoinjector now available in U.S.
Biogen says the LEQEMBI IQLIK autoinjector for initiation of therapy is now available in the U.S. for early Alzheimer’s disease.